CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) returns to the show to talk about licenses granted to them for cannibinoids, working towards precise dosing, and navigating the ever changing regulatory guidelines.

clinical studies # CURE Dots # CURE Film # formulating and manufacturing # malaria # medical # oral thin film # pharmaceutical # product testing # sublingual and transdermal applications # veterinarian products